Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology
Vincenzo Quagliariello, Irma Bisceglia, Massimiliano Berretta, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1397-1397
Open Access | Times Cited: 26
Exosomes derived from LPS-preconditioned bone marrow-derived MSC modulate macrophage plasticity to promote allograft survival via the NF-κB/NLRP3 signaling pathway
Peiyao Zhang, Panfeng Wu, Umar Zeb Khan, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis
Yanan Wang, Dan Fang, Qinzhi Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Evolocumab ameliorates myocardial fibrosis and improves metabolic syndrome–induced cardiac dysfunction in rats via inhibiting PCSK9/NLRP3 inflammasome and Caspase-1 / IL-1β pathways.
Eman Ibrahim Ahmed, Hanan Abdel Moneam Shamardl, Asmaa Mohammed Elsayed, et al.
European Journal of Pharmacology (2025), pp. 177499-177499
Closed Access
The correlation between proprotein convertase subtilisin/kexin type 9 and adiponectin in the progression from prediabetes to type 2 diabetes mellitus
Jun-Xu Gu, Kun Wang, Aimin Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
PCSK9 in Vascular Aging and Age-Related Diseases
Dong Tan, Xin Yang, Jing Yang, et al.
Aging and Disease (2025)
Open Access
Kumquat Flavonoids Attenuate Atherosclerosis in ApoE–/– Mice by Inhibiting the Activation of NLRP3 Inflammasome through Upregulating MicroRNA-145
Linhai Cao, Junli Chen, Hongxia Ni, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review)
Shan Chong, Guangyan Mu, Xinan Cen, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 6
Open Access | Times Cited: 3
PCSK9 aggravated carotid artery stenosis in ApoE-/- mice by promoting the expression of tissue factors in endothelial cells via the TLR4/NF-κB pathway
Chao Peng, Jian Li, Yan Chen, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116314-116314
Closed Access | Times Cited: 3
PCSK9 Confers Inflammatory Properties to Extracellular Vesicles Released by Vascular Smooth Muscle Cells
Maria Francesca Greco, Alessandra Stefania Rizzuto, M Zara, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13065-13065
Open Access | Times Cited: 15
Pyrroloquinoline quinone inhibits PCSK9-NLRP3 mediated pyroptosis of Leydig cells in obese mice
Jinyuan Wang, Shun Zhang, Linlin Hu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 8
Interorgan communication with the liver: novel mechanisms and therapeutic targets
Jiulu Zhao, Xi Zhang, Y. Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Statin administration or blocking PCSK9 alleviates airway hyperresponsiveness and lung fibrosis in high-fat diet-induced obese mice
Lin Liang, Sook In Chung, Taeeun Guon, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
PCSK9 inhibitor protects against ischemic cerebral injury by attenuating inflammation via the GPNMB/CD44 pathway
Yaling Zheng, Tianrui Zhu, Gang Li, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111195-111195
Open Access | Times Cited: 6
Research on Hepatocyte Regulation of PCSK9-LDLR and Its Related Drug Targets
Su-su Liu, Tong Yu, Yan-fang Qiao, et al.
Chinese Journal of Integrative Medicine (2023) Vol. 30, Iss. 7, pp. 664-672
Closed Access | Times Cited: 5
PCSK9 inhibition ameliorates experimental autoimmune myocarditis by reducing Th17 cell differentiation through LDLR/STAT-3/ROR-γt pathway
Miao Yu, Wenjing Tang, Wei Liang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110962-110962
Closed Access | Times Cited: 5
E3 ubiquitin ligase MARCH1 reduces inflammation and pyroptosis in cerebral ischemia-reperfusion injury via PCSK9 downregulation
Hongmei Guo, Wanli Li, Zhi‐gang Yang, et al.
Mammalian Genome (2024) Vol. 35, Iss. 3, pp. 346-361
Closed Access | Times Cited: 1
PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in Cardio-Oncology
Matthew Leonard Repp, Mark D. Edwards, Christopher S. Burch, et al.
Hearts (2024) Vol. 5, Iss. 3, pp. 375-388
Open Access | Times Cited: 1
PCSK9 promotes vascular neointimal hyperplasia through non-lipid regulation of vascular smooth muscle cell proliferation, migration, and autophagy
Qian Zhang, Mengdan Miao, Shan‐Hu Cao, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 742, pp. 151081-151081
Open Access | Times Cited: 1
Novel Thioether‐Bridged 2,6‐Disubstituted and 2,5,6‐Trisubstituted Imidazothiadiazole Analogues: Synthesis, Antiproliferative Activity, ADME, and Molecular Docking Studies
Ibrahim Ozcan, Senem Akkoç, Hakan Alıcı, et al.
Chemistry & Biodiversity (2022) Vol. 20, Iss. 1
Closed Access | Times Cited: 7
Direct Impact of PCSK9 on SMC Senescence and Apoptosis: A New Focus in Cardiovascular Diseases
Xiaoping Wang, Lu Liu, Liyue Zhai, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 7, pp. 1491-1496
Closed Access
Posttransplant complications: molecular mechanisms and therapeutic interventions
Xiaoyou Liu, Junyi Shen, Hongyan Yan, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access
Exosomes derived from LPS-preconditioned bone marrow-derived MSC modulate macrophage plasticity to promote allograft survival via the NF-κB/NLRP3 signaling pathway
Peiyao Zhang, Panfeng Wu, Umar Zeb Khan, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top